BTG Pactual Global Asset Management’s AbbVie ABBV Stock Holding History

BTG Pactual Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$5.39M	–	40
2021 Q3	$5.39M	Buy	+50,000	New	+$5.71M	0.93%	43
2021 Q1	–	Sell	-60,000	Closed	-$6.43M	–	71
2020 Q4	$6.43M	Sell	60,000 -20,000	-25%	-$1.92M	0.9%	21
2020 Q3	$7.01M	Buy	+80,000	New	+$7.53M	0.92%	42
2019 Q4	–	Sell	-210,000	Closed	-$15.9M	–	91
2019 Q3	$15.9M	Buy	210,000 +110,000	+110%	+$7.54M	7.08%	4
2019 Q2	$7.27M	Buy	+100,000	New	+$7.86M	1.82%	11

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BTG Pactual Global Asset Management's ABBV Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 30,600 shares — an estimated $1.79M sold.

BTG Pactual Global Asset Management first reported a position in ABBV in Q4 2013 and held it in 3 quarters. The position peaked at $1.79M in Q1 2015. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

BTG Pactual Global Asset Management reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 30,600 AbbVie shares in Q2 2015, an estimated $1.79M.
BTG Pactual Global Asset Management first reported a position in AbbVie in Q4 2013 and held it in 3 quarters.
BTG Pactual Global Asset Management's AbbVie position peaked at $1.79M in Q1 2015.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.